Sign in to view Olivia’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
CEO at Zest Dermatology
Washington, District of Columbia, United States
Contact Info
Sign in to view Olivia’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
1K followers
500+ connections
Sign in to view Olivia’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
View mutual connections with Olivia
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
View mutual connections with Olivia
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Sign in to view Olivia’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Activity
Sign in to view Olivia’s full profile
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
-
Proud to serve on the board of a company with a 10/10 pen
Proud to serve on the board of a company with a 10/10 pen
Liked by Olivia Deitcher
-
VantAI has inked a partnership with pharma giant Bristol Myers Squibb that hopes to use the body’s cellular waste disposal processes to treat disease.
VantAI has inked a partnership with pharma giant Bristol Myers Squibb that hopes to use the body’s cellular waste disposal processes to treat disease.
Liked by Olivia Deitcher
-
Today is the first day of our Winter 2023 HPIR Academy Program! This group of teams was nominated as the most innovative and high-potential…
Today is the first day of our Winter 2023 HPIR Academy Program! This group of teams was nominated as the most innovative and high-potential…
Liked by Olivia Deitcher
View Olivia’s full profile
Sign in
Stay updated on your professional world
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Other similar profiles
-
Tahmid Hasan
New York, NYConnect -
Rachel Day MD, FAAD
Chambersburg, PAConnect -
Arash Mostaghimi, MD, MPA, MPH
Boston, MAConnect -
Ray Costantini
Portland, ORConnect -
Vivek Ramaswamy
Columbus, OHConnect -
Joyce Hong
New York, NYConnect -
Jason Chouake MD FAAD
Cliffside Park, NJConnect -
Meredith Iverson
Student at Baylor University
St Thomas, PAConnect -
Apolline Jonckheere
Senior Associate at Komodo Health
San Francisco, CAConnect -
Nolan Kartholl
New York City Metropolitan AreaConnect -
Natasha Zaliznyak
New York City Metropolitan AreaConnect -
Devin Solanki
New York City Metropolitan AreaConnect -
Zachary Kanter
New York City Metropolitan AreaConnect -
Anthony Bogachev
MBA/MS in Biotechnology @ Harvard
Cambridge, MAConnect -
Vanessa Florez
Irvine, CAConnect -
Drew Webster
Washington, DCConnect -
Christina Braks
Portland, Oregon Metropolitan AreaConnect -
Katlein França, MD, PhD
Associate Professor of Dermatology- Director of the Psychoneurocutananeous Medicine Center and Contact Dermatitis, Environmental & Occupational Dermatology Center
Miami, FLConnect -
Uday Suresh
PhD Candidate at Vanderbilt University
Nashville, TNConnect -
Amit G.
New York, NYConnect
Explore more posts
-
Christopher K. Lee, MPH
A lot of healthcare startups are built on ideas that seem so obvious. So sensible. Like one of those feel-good concepts that win local pitch competitions. But neat ideas don’t necessarily make good businesses. I met a startup that collects and re-dispenses unused medications. I’ve seen half a dozen variations on this idea of salvaging drugs. On the surface it makes sense. Many people have cupboards full of perfectly good meds. Meanwhile, others are going without the ones they need. So why not redistribute them? First of all, that sounds like a logistical nightmare, for a multitude of reasons I won’t get into here. Second, there are many entrenched interests that would want it to fail. If it becomes a credible threat, they will quash it. More likely though, it’s not even a rounding error - a nuisance they can largely ignore. But in this case, the biggest issue concerned misalignments. 1. Misaligned revenue model. The service is offered as a flat monthly subscription. Whether the client saves $1,000 or $100,000, they pay the same price. That’d be fine except it detaches the revenues from the entire value proposition, i.e., for each prescription, there’s a spread between dispensing a new drug versus one that’s been reclaimed. You can calculate that difference. But the startup cannot capture that value as revenue. So some clients would get a great deal, while others may feel like they’re overpaying. That makes it incredibly difficult to grow the business. 2. Misaligned go-to-market strategy. The startup wants to sell to self-insured employers to save on drug costs. But they don’t have the sales force to approach them directly. So they try to sell through health plans. Seems more scalable. The problem is: Health plans don’t really care what the employers pay. They have little incentive to cut costs for administrative services only clients. It’s all in the execution. Your revenue model should align with the value you deliver. Your go-to-market strategy should align with who receives that value. Otherwise, your neat idea may remain a neat idea. #startups #healthtech #vc #healthcareinnovation #pharmacy
17
4 Comments -
Rishad Usmani, MD
Excited for our webinar tonight: Investing in Healthcare Startups: An Angel Perspective When: tonight at 6 pm eastern Where: https://lnkd.in/dPUFNbhe We had had a couple last minute changes and I am very excited to have an engaging conversation with Thanasi Tsiodras, Dr. Shaun Kuan and Regina Prasad, MS. We will be discussing: 1. How to start investing in startups 2. Lessons from your winners and losers 3. What are some red flags in a startup 4. What is your diligence process like? 5. How do you get deal flow? 6. What is the ideal angel investor archetype? Who should invest in startups and who shouldn't. #healthcare #venturecapital #angelinvesting
27
9 Comments -
Elon Boms
This article by the WSJ is critically important for public health officials and HealthTech entrepreneurs to internalize. We need multiple solutions for patients to move towards post GLP-1 usage. These solutions need to be easy to implement, non-disruptive to daily life and focused on caloric restriction , lifestyle change and muscle gain. Too many startups are still focused on GLP-1 prescription and delivery. Not enough people focused on the next stage of the weight management journey. As the Journal states, the benefits of the GLP-1 craze are only going to be successful long term if the transition off of them is successful. Otherwise, we risk unforeseen, long term consequences to a large group of patients stuck on GLP-1's with no healthy way to transition off. https://lnkd.in/dYBd3HaN Meghan FitzGerald James Stearns Dominic Perks John LaMattina Raju Kucherlapati
29
2 Comments -
Blake Madden
Here's another fundraising roundup spotted in the healthcare wilds 👀 🍃 ✅ Sword Health raised $130M (new valuation: $3B). ✅ Better Health raised $14M to deploy expanded payer partnerships. ✅ Alzheon, Inc. | Preserving Future Memories raised $100M Series E to advance development & commercialization of its Alzheimer’s treatment. ✅ CinRx Pharma raised $73M to continue its ‘Hub and Spoke’ model of startup formation. ✅ Eko Health raised $41M to scale AI-driven heart and lung disease detection. ✅ Anterior (formerly Co:Helm) secured a $20M Series A to unlock admin efficiencies for healthcare payers. ✅ SamaCare raised a $17M Series B to scale specialty drug prior authorization platform. ✅ Plenful secured a $17M Series A to streamline pharmacy operations with AI-powered workflow automation. ✅ Grayce raised a $10.4M Series A led by Maveron amid a caregiving crisis. ✅ Stitch Employment Services Inc PEO raised $8.75M in seed to support independent medical practices. ✅ Posterity Health secured $6M to fund expansion and technology acceleration. ✅ Sware raised $6M to accelerate life sciences innovation by automating FDA-mandated software validation. ✅ Keragon raised $3M, as announced in @Conno Christou’s LinkedIn post. As always, if I missed you, let me know! Each week I'm spotlighting an innovative healthcare startup. I just ask for a bit more transparency. All submissions are confidential; submit yours here 👇 https://lnkd.in/gF4DrAvJ Looking for more fundraising roundups, alongside healthcare industry news and analysis? Subscribe to Hospitalogy, my 2x/week newsletter. Join 33K+ other investors, executives, and healthcare professionals: https://lnkd.in/g-nfRqW6
40
3 Comments -
Harry Goldberg
I am excited to share that our community continues to grow and gather! Since the beginning of the year, we are 15% stronger and have a full calendar for May, including more Dine & Develops and Helpful Hours. Beyond these events, I have an ask and an offer… 🙏DM if you are interested in helping with the operations of the community. There’s so much to do in marketing, growth, sales, support, coordination, low-code and high-code tooling, and more! 💡DM if you want to be featured for a Dine & Develop. I am looking for experts in job positions, functional areas, company types, and problem spaces who want to dine with peers and develop professionally! Furthermore, don’t forget to register for the other upcoming April gatherings – 4/18 Helpful Hour. 🥳 Links in the comment! #CommunityGrowth #NetworkingEvents #ProfessionalDevelopment #VolunteerOpportunities #EventMarketing #CommunityEngagement #CareerDevelopment #BusinessNetworking #SkillBuilding #OperationalExcellence #ProfessionalNetworking #CommunityBuilding #GrowthHacking #PeerLearning #IndustryExperts
23
3 Comments -
Ken Nelson
These 3 proposed changes to RPM reimbursement will be game changers if approved! "Q. Please summarize the proposed changes to RPM coding by the American Medical Association. A. The first – and this would be a very big deal – is the addition of a code that would cover two to 15 calendar days of collected and transmitted data. CPT 99454, the only current general RPM device supply CPT code, can only be used when a provider has received and recorded 16 or more days of patient data within a 30-day period. The addition of a new code would enable providers to code for those 30-day periods where fewer than 16 but at least two readings are captured. The second noteworthy change under consideration is a revision of CPT 99457 to include 11-20 minutes of RPM care management time. 99457 currently requires at least 20 minutes of recorded care management time. Revising 99457 would decrease the amount of time a provider's clinical staff needs to provide RPM monitoring and care management time for a patient during the month to report the code. The third is a revision of CPT 99458 to cover each additional 10 minutes of interactive communication. 99458 currently requires at least an additional 20 minutes of interactive communication. Revising 99458 would reduce the amount of additional time clinical staff must spend to report the code." MedTech Innovator American Heart Association LSI Heart Rhythm Society #epeeps American College of Cardiology MedTech Startup HealthTech Arkansas
31
-
Michael Paris
I’m more of a value + application person. I’ve worked with amazing tech developers who keep my guardrails up, but developing new products for product-market fit is key. That said, I want to show appreciation to NYU Langone Health's initiative to use AI for making doctors' notes more patient-friendly. It is a testament to the potential of generative AI in enhancing healthcare communication. This approach not only promises to bridge the gap between patient understanding and professional medical knowledge but also showcases the practical value of AI in improving patient-provider interactions. By making health information more accessible, we're stepping into a future where healthcare is inclusive, empowering patients through education. This development represents a promising application of generative AI with significant product value. Learn more here.
1
-
Multiplier Advisors
IYMI: Multiplier's Colby Dailey is co-hosting the next Tideline Compass Series session on 4/17, "Anchoring in Social Determinants: A Closer Look at Health-Focused Investing." It's not too late to register, just sign up here: https://lnkd.in/ejyJn7dg #impactinvesting #healthcare #anchormission #sdoh
2
-
Josh Shoemaker
These are all great insights on how to improve consumer education and #healthliteracy but in my view a glaring gap remains. The reality in healthcare is we're talking about a significant amount of information asymmetry when it comes to patients and providers. This leads to an underlying institutional hubris I have encountered at each stop along my healthcare journey - some places more toxic and pervasive than others. I would suggest in addition to these practical steps, we as leaders in the health system need to daily look ourselves in the mirror and check our ego - this subtle culture shift would go a long way towards industry transformation. https://lnkd.in/gpjm68Bd
2
-
Rishad Usmani, MD
Technology in its current state is worsening the physician crisis. There seems to be a new referral pathway every month with unlimited check boxes and data for us to input. Each often requiring a new log in and at times two factor authentication. It seems with every new tech in healthcare we spend more time interacting with the tech and less time interacting with our patients. The solution is simple, if the tech in question results in decreased physician-patient time then it shouldn’t be rolled out. The one thing to keep in mind is say you’re rolling out a new patient intake form for referrals for MRIs to better triage patients. It’s important to think about the downstream effects of who will fill out this form and the time needed to do so. As a front line physician every new referral intake pathway increases my admin burden and endpoint burnout. In an ideal world I simple type “MRI lumbar spine” in my EMR and all the data is auto populated. Sadly this almost never happens. #primarycare #healthcare #familyphysician
29
5 Comments -
Blake Madden
Bigger isn't always better in healthcare. Just look at the graphic below. Some of the largest health systems in the country are underperforming. They've entered (or operate in) bad markets, hold bloated cost structures, and struggle to hold leverage against payors. As it turns out, and as I'm often reminded, market performance matters. It doesn't matter that you're just big and can absorb a vast swath of overhead. As a health system, the way you throw your weight around in markets is more important than ever. This is the key concept of density and having the right assets in the right markets. CVS, HCA, Tenet, and others all have mentioned the importance of market density in 2024. Density - and being dense in attractive markets - is primarily what separates -3.9% from 10%+ operating margins. I should have paid attention in physics!! PS: if you like graphics and analysis like this, subscribe to my newsletter Hospitalogy here with 34k+ others: https://lnkd.in/gniNmHvz
162
15 Comments -
Katrina Roundfield, PhD
What is it like to witness a health tech startup grow from seed stage to a $72M Series C? I joined Two Chairs as a founding team member in 2017. We had no clinic, no clinicians, and no clients. Just 4 people in a co-working space dreaming big. Not all mental health tech companies are made equal. This one was made different. Two Chairs was made with a keen eye towards both the client AND the therapist experience. Across the years, I feel most proud of the therapists who have brought the company to where it is today. - I think of Nathan Greene, Psy.D. who wrote Two Chairs’ first ever clinic manual because he wanted all clinicians to have a seamless transition into their role at the company - I think of Anna Sapozhnikova, Ph.D. and Hannah Klempner, PsyD who designed and scaled the matching model to ensure clinicians and clients had excellent experiences in care - I think of Nassim Bickham, LMFT who successfully secured APA accreditation for clinicians’ continuing education. - I think of Namrata Doshi who challenged me to reconsider how we think about clinician utilization - I think of every one of our clinical directors who built the clinical care foundation while we scaled - I think of Nick Forand, PhD, ABPP who is leading a team focused on enhancing clinical innovation - I think of Colleen Marshall who is working day in and day out to create the best clinician culture across a nationwide team Two Chairs is different because it was designed by therapists. The clinician experience was always a part of Alex Katz’s vision and I feel honored to have helped bring this vision to life. If you are a therapist, I encourage you to get in touch with the Two Chairs team and learn more about how clinicians experience Two Chairs. Alicia Eggen, LMFT Allyson Holmes-Knight, Ph.D. Justin Davella, Psy.D. Christy Lusareta, MA, LMFT Baaba Hawthorne, M.A., LMFT Will Alexander, LMFT Zlatena Theodore,Psy.D. Sona Trivedi, LMFT Victoria Bangieva, PhD https://lnkd.in/gT3UVfpP
126
11 Comments -
Dr. Jyoti Dongre Rao
#Niche-focused #ventures in #HealthTech, such as those #targeting #underserved areas or #specific health conditions, offer several benefits. They can address gaps in the #healthcare system, provide specialized care, and #potentially integrate into broader #ecosystems for comprehensive healthcare solutions. For example, #JVEDTECHMedovation, could explore #partnerships with #niche #HealthTech startups to enhance offerings in healthcare #innovation.
1
-
Harry Goldberg
For #MemberMonday, please meet Kristen Berman, CEO & Co-Founder of Irrational Labs. Her team specializes in behavioral economics, driving engagement in HealthTech. Plus, she has an awesome product teardown Substack, and started a compound featured in The New York Times, Vox, and The Atlantic 🚀 𝗧𝗲𝗹𝗹 𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝘆𝗼𝘂𝗿𝘀𝗲𝗹𝗳 I’m CEO & Co-Founder of Irrational Labs. We’re a behavioral economics and design consulting shop that works on behavior change; we co-founded Google's behavioral economics group. I also have a popular Substack where I do product teardowns (link in comment) Fun fact: I started a 20-person compound in Oakland called Radish, featured in The New York Times, Vox, and The Atlantic (link in comment) 𝗧𝗲𝗹𝗹 𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝘆𝗼𝘂𝗿 𝗰𝗼��𝗽𝗮𝗻𝘆 At Irrational Labs, we are experts at behavior change, focused on driving engagement for patients, members, and providers. We give you psychology insights about your users and translate those into behavior-change strategies and designs. Sample projects include: • One Medical's onboarding flow, driving a 20% lift in bookings\ • Optum's and other payers’ product launches, telehealth adoption, and mobile app design • Behavior change strategy and design for Roche, Belong Health, Talkspace, TytoCare, and Aetna, a CVS Health Company • Partner regularly with the biggest names in the Valley (LinkedIn, Intuit, PayPal) If you need to understand and build for your user’s psychology -- hit us up! We’d love to talk with you. You can send me (Kristen Berman) a DM or email at kristen@irrationallabs.com. 𝗛𝗼𝘄 𝗵𝗮𝘀 HealthTech Hang 𝗺𝗮𝗱𝗲 𝗮𝗻 𝗶𝗺𝗽𝗮𝗰𝘁? I went to a HealthTech Hang dinner and made a friend AND got a warm intro to a potential client! #MemberMonday #HealthTech #BehaviorChange
25
2 Comments -
Mario Amaro, MD
“I think it’s important that the person running the organization understands the core thing that the company does.” - Ben Horowitz, GP at a16z. Totally agree, but we actually see the opposite in healthcare. As care delivery businesses are mostly run by people who have no prior knowledge of how to deliver care. The ACA actually prohibits doctors from even owning hospitals. Which completely enables MBAs and other non-clinical administrators to influence how patients receive care. Call me old fashioned but shouldn’t the people trained and licensed to provide care delivery services be the ones running businesses where care services are delivered? 🤷🏽♂️ —— Hi, I'm Dr. Mario Amaro, Founder and CEO Ease and I talk about all things starting, running, and growing a private practice with AI. Follow me, if you are planning to start one or are currently figuring out creative ways to grow one. #PrivatePractice #SelfEmployment #HealthcareOnLinkedin #HeyEase #IndependentTogether
10
4 Comments -
Stacy Mays
Interesting to see that digital health funding is relatively stable. Only a couple of exits. I think we'll see more deals like DarioHealth's acquisition of Twill, since from a sales perspective, the narrower the solution, the more difficult it is to acquire customers. This difficulty has nothing to do with the quality of offerings, but with the data management and administrative complexity on the customer side.
2
-
Sam Qamar
Walmart is exiting healthcare. This doesn’t surprise me. Walmart was never designed for healthcare, it was designed for retail. Everyone wants a piece of the $4T pie, but it’s a pie full of indigestible ingredients that would make the biggest companies choke. Especially companies that were never built for healthcare. - fee-for-service doesn’t work, especially with very low fees - relying on legacy payors doesn’t work - using insurance for primary care doesn’t work - not paying providers enough doesn’t work - having a clinic next to gardening supplies doesn’t work Throwing millions at healthcare doesn’t automatically work with a large base that comes to you for something else. I believe a properly built and well-executed healthcare startup that “thinks differently”, will eventually move the needle on improving the American healthcare experience. It’s coming, and will surprise everyone.
192
52 Comments -
Bobby Guelich
Here’s your recap of last week’s health IT news 🗞️ Notable partnerships 🤝 • Kaiser Permanente is partnering with Innovaccer to incorporate their population health and AI platform • MUSC Health adopted Andor Health’s ThinkAndor in its ED to reduce wait times and “leaving without being seen” rates. • Upperline Health is partnering with Navina to improve clinical workflows and improve the accuracy of patient histories. • Intermountain Health deployed Nuance Communications DAX Copilot, an AI ambient scribe solution. • PA Clinical Network is partnering with Guidehealth to improve outcomes and care quality while improving physician efficiency. Product updates 👩🏼💻 • Klara released a new patient intake product for athenahealth users. • Baton Health released Universal Primary Source, giving users access to hundreds of primary source databases for credentialing. • InsightRX released InsightRX Apollo, an analytics platform that provides insights on clinical performance. • Trovo Health launched with a $15 million seed round, offering specialty-specific AI combined with clinical experts to help practices add to their capabilities. • Quest Diagnostics acquired PathAI’s diagnostic laboratory business (PathAI Diagnostics) to improve Quest’s oncology services. • GenHealth.ai launched its Automated Prior Authorization platform. • Veradigm® is partnering with MedEvolve, Inc. to make its suite of products available to Veradigm users. • CLEW announced availability of a newly FDA-approved patient surveillance platform. Posts we enjoyed 👏 • Eric Topol, MD shared a compelling piece reviewing the state of research on AI in medicine. In short, we’re seeing our first early evidence that AI can reduce mortality as a research endpoint, but large language models are not yet the panacea we’ve been promised. (https://lnkd.in/e6hK-4mr) • Nikhil Krishnan of Out-Of-Pocket shared a deep dive on Stedi, which converts X12 EDI into JSON-based APIs for healthcare tech developers. (https://lnkd.in/eqS9V5zW) --- Want to stay in the loop? Sign up for the Elion Briefing to get all of the latest healthcare tech news delivered to your inbox 📬 👉 https://bit.ly/49z6AUW
70
5 Comments -
Ellen Brown
What I learned this week. Mo money mo problems. I want to know more about what Better Health's $14M Naama Stauber Breckler to "expand payer partnerships" better yet what will Sword Health Virgílio (“V”) Bento be doing w/$130M (plug for healthcare not sickcare) Blake Madden & I have Johannes Boshkow to fuel my "hope springs eternal" for innovation w/his piece on good stuff pharma is doing in #digitalhealth We need a list of the Medicare Advantage (MA) plans that had their STAR ratings bumped (Bueller? I turned over a few rocks came up empty). Organizations rely on a % of premium on MA from plans, for many it's the what keeps them open. That bump could mean 5% more revenue (hello any chance of a margin - Oak Street Health Mike Pykosz surely wants to know...) yet these orgs have no public visibility into who got the favorable adjustment. We know congrats is in order for Clover Health Andrew Toy and of course SCAN Sachin H. Jain, MD, MBA and Elevance Health who took one for the MA team. Liz F.? Still processing FDA overturn to approve Sarepta gene therapy ($3.2M cost) for Duchanes Muscular Dystrophy - "upending clinical trials" Stacy Mays... Makes me think of the conversation Carter Williams and I had this am that maybe future insurance includes a government funded reinsurance plan for those w/lifetime diease Stumbled upon multiple posts by Pranay Kapadia of Notable (including re:Community Health Network - I'm a fan of Patrick McGill, MD MBA) and now I'm intrigued - I keep saying AI for reducing admin burden I'm not a fan of polarization - finger pointing has never yielded good. Let's focus on CREATING an actual healthcare delivery & insurance system vs. our sickcare based care delivery & insurance system. I'm curious to read what Sachin H. Jain, MD, MBA plans to do Eric Wicklund. Plus, between the Wash Post article about leaked documents revealing patient safety issues at One Medical (publicly traded margin focus?) Luciano Fochesatto and GLP-1 research emerging about drop outs Deborah Williams this week it's a must. Plenty of people are willing to do the hardwork to reverse their lifestyle disease! Good news - the work is underway Carter Williams Katie Stebbins Erin Martin Martin Tull Zuzanna Zielińska Oh and the recent Senate testimony reminding us "food is health - nothing else in healthcare - the single largest sector of our economy - with that promise" Fredéric Laforge VBC 2.0 perhaps - Blue Shield of California Paul Markovich stepping up to the plate w/a self-insured client (not to mention 1 of the nation's largest) CalPERS to put 75% ($350m) of their admin fees (think claims processing) at risk based on care cost & quality opens up a lot for new models of care delivery for self-insured clients where all entities can be aligned economically vs. the insurer just taking their fees & saying "we'll try". Speaking of VBC 2.0 Yubin Park, PhD shared a great piece on VBC and dashboards - despite being on vacation in Korea no less
26
6 Comments -
Joseph Pazona
CME - “I’ll take well intentioned, comical moneymaking schemes in healthcare for $200 Alex” Add continuing medical education (CME) to the long list of healthcare verticals that get it wrong. I’d love to share a story about how not understanding CME cost me $1000 plus a negative course of action on my national practitioners database record. In the state of Alabama, you must perform 25 hours of CME per year. I went to a conference that counted for 22 hours. Since I was a faculty member with a university, I mistakenly thought that medical school lectures that I had organized and legitimately given, counted for the other 3 hours. I was wrong. I was audited. I was asked for a certificate. I answered, “what certificate?” I was fined and reprimanded. I didn’t learn this crap in residency? How was I to know what counted as category 1 CME? Oh that’s right! It’s the stuff that makes someone else money that counts. I gotcha. Unless you spend thousands of dollars to go to some conference in San Antonio, or even worse, hundreds of dollars to take some online test that is useless, your educational activities “don’t count.“ Are there free CME activities? Absolutely. But you get what you pay for. More importantly isn’t the time of doctors worth something a little more valuable? I don’t know maybe like taking care of patients? Unfortunately, there’s not much we can do about these mandatory regulations. Maybe the best thing we can do is get a group of us disruptors together, form our own accredited conference, and work to solve the broken healthcare system. I’ll suggest Tuscany, but I’m open to suggestions. #cme #physicianburnout #physicians #healthcare #medicaleducation #physicianwellness
27
26 Comments
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More